Opioid Prescription Incentives is sales bonuses and prescriber relationships fueled mass over-prescription and an addiction crisis. It sits in the Incentives dimension (INC) of the Human Behavior Taxonomy™ as element HBT-INC-0196, within the Healthcare Perverse Pattern family. The core principle: sales bonuses and prescriber relationships fueled mass over-prescription and an addiction crisis. In incentive terms, it matters because it changes the payoff people perceive before they choose — which means it can be designed for, or exploited.
Scientific Definition
Sales bonuses and prescriber relationships fueled mass over-prescription and an addiction crisis.
Plain-English Definition
Sales bonuses and prescriber relationships fueled mass over-prescription and an addiction crisis.
Feynman Explanation
Pay the rep per pill, and you'll get a country full of pills.
Core Principle
Sales bonuses and prescriber relationships fueled mass over-prescription and an addiction crisis.
Mechanisms
Pending editorial review.
Sales bonuses and prescriber relationships fueled mass over-prescription and an addiction crisis.
Pending editorial review.
Pending editorial review.
Sales-force comp design as public-health hazard.
Pending editorial review.
Pending editorial review.
Inputs (Triggers)
Pending editorial review.
Outputs (Behaviors)
Pending editorial review.
Behavioral Signature
Pay the rep per pill, and you'll get a country full of pills.
Examples
- Purdue's OxyContin sales model and downstream addiction wave.
- Sales-force comp design as public-health hazard.
Pending editorial review.
Original analysis from The Incentives Lab — how this element behaves inside real payoff structures.
Why this element matters to incentive design
The mistake with this element is treating it as irrationality. It is almost always a rational response to a payoff nobody wrote down. The mechanism underneath it is straightforward: sales bonuses and prescriber relationships fueled mass over-prescription and an addiction crisis. You can recognize it in the field by its signature: pay the rep per pill, and you'll get a country full of pills. Every element in the Incentives dimension changes the perceived payoff of an action before the action happens, which is exactly where incentive design has leverage.
How it gets exploited
Left undesigned, sales-force comp design as public-health hazard. It is amplified whenever sales-force comp design as public-health hazard. Inside organizations that shows up as sales-force comp design as public-health hazard. The pattern is the same one Goodhart's Law describes: the measurable proxy attracts the effort, and the purpose behind it quietly loses funding.
How the Lab designs around it
The redesign move is to decouple rep pay from script volume. Independent prescriber education. Watch for it at the boundaries: handoffs, promotions, incident reviews, and budget cycles are where this element gets its power.
Famous Experiments
Pending editorial review.
Design Principles
- Decouple rep pay from script volume. Independent prescriber education.
Measurement Approaches
Pending editorial review.
Evidence
Pending editorial review.
Pending editorial review.
The Perverse Incentive Lens™
How this behavior is exploited — and how to redesign around it.
- Decouple rep pay from script volume. Independent prescriber education.
Pending editorial review.
Pending editorial review.
Interactive Mini Network
Click any neighbor to re-center the graph and follow the threads of connection.
Knowledge Graph Neighbors
Auto-linked to the rest of the Human Behavior Taxonomy by family, domain, dimension, and shared keywords.
Productivity targets compress visits, raising misdiagnosis and burnout.
A federal mandate intended to lower drug costs for the poor became a profit engine for hospitals and contract pharmacies.
Liability exposure pushes clinicians to order tests for legal protection rather than clinical need.
Federal reimbursement rules incentivize cycling seniors through hospitalizations to upgrade billing categories.
Paying providers per procedure rewards more procedures, not better outcomes.
Systems paid per filled bed have weak incentives to invest in prevention or community health.
Opaque billing rules create lucrative work for administrators and revenue-cycle firms instead of care.
Insurers profit when claims are denied, delayed, or abandoned.
Hospital group-purchasing and opaque contracting inflate device costs far above marginal cost.
Federal incentives meant for neglected diseases get used to privatize widely available medicines.
Drug companies optimize for high-margin chronic conditions, not cures.
Specialists earn more for procedures than primary care for prevention.
Where Opioid Prescription Incentives is cited in the corpus
Essays, field guides, and diagnostics from The Incentives Lab that apply this element.
- Field guideIncentives: definition, types, examples
The parent field guide for this element.
- ReferenceThe laws of incentives
Goodhart, Campbell, and the Cobra Effect.
- EssayIncentives Under Crisis
How this element behaves under pressure.
- ReferenceThe Periodic Table of Human Behavior
The full 1,267-element map this page belongs to.
- ReferenceThe incentive glossary
Definitions for every mental model, bias, and fallacy in the corpus.
Questions about Opioid Prescription Incentives
- What is Opioid Prescription Incentives?
- Opioid Prescription Incentives is sales bonuses and prescriber relationships fueled mass over-prescription and an addiction crisis. It sits in the Incentives dimension (INC) of the Human Behavior Taxonomy™ as element HBT-INC-0196, within the Healthcare Perverse Pattern family. The core principle: sales bonuses and prescriber relationships fueled mass over-prescription and an addiction crisis. In incentive terms, it matters because it changes the payoff people perceive before they choose — which means it can be designed for, or exploited.
- What is an example of Opioid Prescription Incentives?
- Sales-force comp design as public-health hazard. The Incentives Lab catalogs everyday, organizational, and historical instances of this element on its Human Behavior Taxonomy™ page (HBT-INC-0196).
- How is Opioid Prescription Incentives exploited?
- Sales-force comp design as public-health hazard.
- How do you design around Opioid Prescription Incentives?
- Decouple rep pay from script volume. Independent prescriber education.
- Which behavioral dimension does Opioid Prescription Incentives belong to?
- Opioid Prescription Incentives is classified in the Incentives dimension (INC) of the Human Behavior Taxonomy™, family "Healthcare Perverse Pattern", class "Perverse Incentive". Its permanent identifier is HBT-INC-0196 and its evidence grade is C.